Use of Complementary Health Approaches Among Diverse Primary Care Patients with Type 2 Diabetes and Association with Cardiometabolic Outcomes: From the SF Bay Collaborative Research Network (SF Bay CRN)

References

1. 1.↵
   National Institute of Health. Complementary, alternative, or integrative health: What's in a name? 2016. Available from: https://nccih.nih.gov/health/integrative-health.
2. 2.↵
   1. Chang HY,
   2. Wallis M,
   3. Tiralongo E

   . Use of complementary and alternative medicine among people living with diabetes: Literature review. J Adv Nurs 2007;58:307–19.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Laiyemo MA,
   2. Nunlee-Bland G,
   3. Lombardo FA,
   4. et al

   . Characteristics and health perceptions of complementary and alternative medicine users in the United States. Am J Med Sci 2015;349:140–4.

   OpenUrlPubMed
4. 4.↵
   U.S. Department of Health and Health Services, National Institute of Health, National Center for Complementary and Alternative Medicine. Exploring the science of complementary and alternative medicine (NIH Publication No. 11–7643). 2015.
5. 5.↵
   1. Chao MT,
   2. Handley MA,
   3. Quan J,
   4. et al

   . Disclosure of complementary health approaches among low income and racially diverse safety net patients with diabetes. Patient Educ Couns 2015;98:1360–6.

   OpenUrl
6. 6.↵
   1. Clarke TC,
   2. Black LI,
   3. Stussman BJ,
   4. et al

   . Trends in the use of complementary health approaches among adults: united states, 2002–2012. National Health Statistics Report; No. 79. Hyattsville, MD: National Center for Health Statistics; 2015.
7. 7.↵
   1. Chao MT,
   2. Wade CM

   . Socioeconomic factors and women's use of complementary and alternative medicine in four racial/ethnic groups. Ethn Dis 2008;18:65–71.

   OpenUrlPubMed
8. 8.↵
   1. Pagán JA,
   2. Tanguma J

   . Health care affordability and complementary and alternative medicine utilization by adults with diabetes. Diabetes Care 2007;30:2030–1.

   OpenUrlFREE Full Text
9. 9.↵
   1. Maclennan AH,
   2. Wilson DH,
   3. Taylor AW

   . The escalating cost and prevalence of alternative medicine. Prev Med 2002;35:166–73.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Nahin RL,
    2. Byrd-Clark D,
    3. Stussman BJ,
    4. et al

    . Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: Data from the 2002 and 2007 National Health Interview survey. BMC Complement Altern Med 2012;12:193.

    OpenUrlPubMed
11. 11.↵
    1. Nahin RL,
    2. Barnes PM,
    3. Stussman BJ

    . Expenditures on complementary health approaches: United States, 2012. Natl Health Stat Report 2016;22;(95):1–11.

    OpenUrl
12. 12.↵
    1. Nguyen H,
    2. Sorkin DH,
    3. Billimek J,
    4. et al

    . Complementary and alternative medicine (CAM) use among non-Hispanic white Mexican American, and Vietnamese American patients with type 2 diabetes. J Health Care Poor Underserved 2014;25:1941–55.

    OpenUrl
13. 13.↵
    1. Garrow D,
    2. Egede LE

    . National patterns and correlates of complementary and alternative medicine use in adults with diabetes. J Altern Complement Med 2006;12:895–902.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Nguyen LT,
    2. Davis RB,
    3. Kaptchuk TJ,
    4. et al

    . Use of complementary and alternative medicine and self-rated health status: Results from a national survey. J Gen Intern Med 2011;26:399–404.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gohar F,
    2. Greenfield SM,
    3. Beevers DG,
    4. et al

    . Self-care and adherence to medication: A survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008;8:4.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Krousel-Wood MA,
    2. Muntner P,
    3. Joyce CJ,
    4. et al

    . Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: Findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2010;58:54–61.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Jernewall N,
    2. Zea MC,
    3. Reisen CA,
    4. Poppen PJ

    . Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men. AIDS Care 2005;17:601–9.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Koren R,
    2. Lerner A,
    3. Tirosh A,
    4. et al

    . The use of complementary and alternative medicine in hospitalized patients with type 2 diabetes mellitus in Israel. J Altern Complement Med 2015;21:395–400.

    OpenUrl
19. 19.↵
    1. Marcus DM,
    2. Grollman AP

    . Toxicity of botanical medicines: An overlooked global health problem. Am J Public Health 2016;106:16–7.

    OpenUrl
20. 20.↵
    1. Corbin Winslow L,
    2. Shapiro H

    . Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002;162:1176–81.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Ratanawongsa N,
    2. Handley MA,
    3. Quan J,
    4. et al

    . Quasi-experimental trial of diabetes self-management automated and real-time telephonic support (SMARTSteps) in a Medicaid managed care plan: Study protocol. BMC Health Serv Res 2012;12:22.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Ratanawongsa N,
    2. Karter AJ,
    3. Quan J,
    4. et al

    . Reach and validity of an objective medication adherence measure among safety net health plan members with diabetes: A cross-sectional study. J Manag Care Spec Pharm 2015;21:688–98.

    OpenUrl
23. 23.↵
    American Diabetes Association. Unproven therapies. Diabetes Care 2004;27(Suppl 1):S135.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Chew LD,
    2. Griffin JM,
    3. Partin MR,
    4. et al

    . Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med 2008;23:561–6.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Sarkar U,
    2. Schillinger D,
    3. López A,
    4. Sudore R

    . Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. J Gen Intern Med 2011;26:265–71.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Sarkar U,
    2. Piette JD,
    3. Gonzales R,
    4. et al

    . Preferences for self-management support: Findings from a survey of diabetes patients in safety-net health systems. Patient Educ Couns 2008;70:102–10.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Kronenberg F,
    2. Cushman LF,
    3. Wade CM,
    4. et al

    . Race/ethnicity and women's use of complementary and alternative medicine in the United States: Results of a national survey. Am J Public Health 2006;96:1236–42.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Karter AJ,
    2. Parker MM,
    3. Moffet HH,
    4. et al

    . New prescription medication gaps: A comprehensive measure of adherence to new prescriptions. Health Serv Res 2009;44(5 Pt 1):1640–61.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Nichter M,
    2. Thompson JJ

    . For my wellness, not just my illness: North Americans' use of dietary supplements. Cult Med Psychiatry 2006;30:175–222.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Egede LE,
    2. Ye X,
    3. Zheng D,
    4. et al

    . The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002;25(2):324–9.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Yeh GY,
    2. Eisenberg DM,
    3. Davis RB,
    4. et al

    . Use of complementary and alternative medicine among persons with diabetes mellitus: Results of a national survey. Am J Public Health 2002;92:1648–52.

    OpenUrlPubMedWeb of Science